The activity of your compound is determined by proliferation assays on a cancer cell line panel of 102 tumor cell lines. The drug response data are subjected to bioinformatics analysis to help you determine patient stratification markers for clinical trials. We have full commercial licences from the ATCC for use of the cell lines. The bioinformatics analysis is available for proliferation data from the Oncolines™ cancer cell line panel as well as proliferation data that have been generated elsewhere.
Oncolines ™NTRC Oncolines2020-04-03T15:22:22+02:00